Epilepsy Ireland

Lobbying Organisation Epilepsy Ireland

Date published 16 Sep, 2020

Relevant Matter Public policy or programme

Public Policy Area Health

Period 1 May, 2020 to 31 Aug, 2020

Specific Details Communications with Deputy Marian Harkin on issue of sodium valproate

Intended results Inform Deputy on the issues around sodium valproate including risk minimisation, seek her support for Epilepsy Ireland's positions on need to further reduce risks and address historical issues

Name of person primarily responsible for lobbying on this activity Peter Murphy

Did any Designated Public Official(DPO) or former Designated Public Official(DPO) carry out lobbying activities on your behalf in relation to this return? You must include yourself, and answer Yes, if you are a current DPO or a DPO at any time in the past. (What is a Designated Public Official?) No

Did you manage or direct a grassroots campaign? No

Was this lobbying done on behalf of a client? No

Lobbying activity

The following activities occurred for this specific Subject Matter Area.

Social Media (2-5)

Tagged Deputy on social media posts

Phone call (2-5)

Email (2-5)

Informal communication (2-5)

Participated with Deputy Harkin on local radio interviews on subject of valproate - Epilepsy Ireland survey results on knowledge of risks and on launch of UK IMMDS Report on Medicines safety.

Designated public officials lobbied

The following DPOs were lobbied during this return period on this specific Subject Matter Area. These DPOs were involved in at least one of the Lobbying Activities listed above, but not necessarily all of them. As returns are specific to a Subject Matter Area the above Lobbying Activities may be associated with multiple returns.

Marian Harkin TD (Dáil Éireann, the Oireachtas)